SOW
TGTX icon

State of Wyoming’s TG Therapeutics TGTX Stock Holding History

State of Wyoming’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-251
Closed -$7.55K – 1843
2024
Q4 		$7.55K Buy
+251
New +$7.2K ﹤0.01% 1541
2022
Q1 		– Sell
-223
Closed -$4K – 2016
2021
Q4 		$4K Sell
223
-55
-20% -$1.43K ﹤0.01% 1740
2021
Q3 		$9K Sell
278
-201
-42% -$6.22K 0.01% 1044
2021
Q2 		$19K Buy
479
+283
+144% +$11.1K 0.01% 936
2021
Q1 		$9K Buy
+196
New +$9.42K 0.01% 400

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State of Wyoming's TGTX Position: Q1 2025 in Review

State of Wyoming sold out of TG Therapeutics (TGTX) in Q1 2025, closing a stake of 251 shares — an estimated $7.55K sold.

State of Wyoming first reported a position in TGTX in Q1 2021 and held it in 5 quarters. The position peaked at $19K in Q2 2021. 376 funds tracked by Wall St. Rank hold TGTX as of Q1 2025.

  • State of Wyoming reported no remaining TG Therapeutics position as of Q1 2025 after selling out during the quarter.
  • State of Wyoming sold 251 TG Therapeutics shares in Q1 2025, an estimated $7.55K.
  • State of Wyoming first reported a position in TG Therapeutics in Q1 2021 and held it in 5 quarters.
  • State of Wyoming's TG Therapeutics position peaked at $19K in Q2 2021.
  • 376 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2025.

Based on State of Wyoming's 13F filing for Q1 2025, filed 14 May 2025.